Rheumatology · Las Vegas, NV
NPI
1619944113
Since 2006
Specialty
Rheumatology
Code 174400000X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
7200 Cathedral Rock Dr, #110
Las Vegas, NV, 89128
Phone (702) 341-5444
Medicare paid, 2024
$1.0M
93,883 services
Medicare patients, 2024
583
Average age 74
Drug cost, 2024
$4.3M
5,437 prescriptions
Company payments, 2025
$14K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George T Kelly was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 28,600 times for 11 patients. In total George T Kelly billed 93,883 services in 51 codes, and Medicare paid $1.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-25.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 28,600 | 11 | $3.61 | $103K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 6,350 | 17 | $9.35 | $59K |
| J0897 Injection, denosumab, 1 mg | Office | 5,280 | 57 | $20.20 | $107K |
| J2357 Injection, omalizumab, 5 mg | Office | 4,545 | 14 | $29.59 | $134K |
| Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | Office | 2,630 | 17 | $22.96 | $60K |
| Q5119 Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | Office | 2,351 | 11 | $16.42 | $39K |
| 99213 Office E&M - Established | Office | 683 | 361 | $63.19 | $43K |
| 99214 Office E&M - Established | Office | 416 | 264 | $92.31 | $38K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 325 | 77 | $0.49 | $158 |
| 96372 Injection Administration | Office | 182 | 45 | $10.88 | $1,980 |
| 96415 Chemotherapy Administration | Office | 176 | 34 | $21.26 | $3,741 |
| 96365 Intravenous Infusion, Hydration | Office | 174 | 49 | $45.30 | $7,882 |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 157 | 15 | $0.11 | $16.49 |
| 96413 Chemotherapy Administration | Office | 128 | 34 | $97.05 | $12K |
| 99205 Office E&M - New | Office | 104 | 104 | $151.07 | $16K |
By year: 2022 $1.8M for 99,768 services; 2023 $1.7M for 112,431 services; 2024 $1.0M for 93,883 services.
Medicare prescription drug claims, 2024
In 2024, the drug George T Kelly prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 920 prescriptions and refills. In total George T Kelly wrote 5,437 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 920 | 2,584 | 301 | $23K |
| Prednisone Generic | 730 | 1,912 | 276 | $6,068 |
| Hydroxychloroquine Sulfate Generic | 618 | 1,722 | 199 | $27K |
| Sulfasalazine Generic | 415 | 1,156 | 150 | $14K |
| Leflunomide Generic | 292 | 841 | 101 | $17K |
| Folic Acid Generic | 138 | 389 | 45 | $1,654 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 131 | 131 | 23 | $2,356 |
| Gabapentin Generic | 126 | 312 | 46 | $1,458 |
| Humira(Cf) Pen Adalimumab | 118 | 122 | 14 | $944K |
| Tramadol Hcl Generic | 89 | 89 | 18 | $393 |
| Alendronate Sodium Generic | 84 | 213 | 30 | $639 |
| Enbrel Sureclick Etanercept | 79 | 93 | 12 | $704K |
| Allopurinol Generic | 79 | 216 | 24 | $546 |
| Leucovorin Calcium Generic | 75 | 212 | 22 | $2,633 |
| Ibandronate Sodium Generic | 62 | 183 | 23 | $1,420 |
Brand drugs: 1,020 claims; generic drugs: 4,398 claims; opioid claims: 257.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George T Kelly $14K ($14K in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $12K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 31 | $12K |
| UCB, Inc. UCB.BR | 23 | $515 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $264 |
| Janssen Biotech, Inc. JNJ | 23 | $257 |
| Amgen Inc. AMGN | 10 | $175 |
| ANI Pharmaceuticals, Inc. ANIP | 7 | $154 |
| Genzyme Corporation SNY | 2 | $145 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $120 |
| Organon LLC OGN | 6 | $120 |
| Sobi, Inc SOBI.ST | 3 | $71.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.